The city of Rochester, New York, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Oral Ifetroban in Patients with Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
01/23/2025
Locations: University of Rochester, Rochester, New York
Conditions: Idiopathic Pulmonary Fibrosis